There are limited studies about the molecular characteristics and clinical response to EGFR TKIs in NSCLC patients harboring EGFR E709-T710delinsX mutation, a rare mutation type in exon 18 of EGFR. In this study, we aimed to explore the molecular distribution and clinical outcome of EGFR TKIs in EGFR E709-T710delinsX mutated patients.